Archives of physical medicine and rehabilitation · 2026
Focal Muscle Vibration for Upper Limb Spasticity After Stroke: A Systematic Review and Meta-Analysis.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Mingyu, Zhou Dan, Wu Fan, Li Yang, Meng Dianhuai
Аннотация
OBJECTIVE: To estimate the effect of focal muscle vibration (FMV) on poststroke upper limb spasticity and explore whether frequency, amplitude, or target joint moderates effects.
DATA SOURCES: PubMed, Excerpta Medica Database, Web of Science, Cumulative Index to Nursing and Allied Health Literature, PEDro, and Cochrane Central Register of Controlled Trials were searched from inception through March 2026.
STUDY SELECTION: Studies of adults with poststroke upper limb spasticity were eligible if they applied FMV to the upper limb and reported the Modified Ashworth or Tardieu Scale. Controlled parallel, randomized crossover, and comparative repeated-measures studies were eligible, including peer-reviewed reports and preprints with sufficient outcome data.
DATA EXTRACTION: Two reviewers independently extracted data and assessed the risk of bias. Hedges' g was calculated from pre-to-post change scores and synthesized with a 3-level random-effects model (restricted maximum likelihood). Certainty was assessed with the Grading of Recommendations Assessment, Development, and Evaluation. The review was registered in PROSPERO (CRD420251181549).
DATA SYNTHESIS: In total, 11 reports representing 11 independent participant samples contributed 32 effect estimates from 285 participants assigned to or receiving an FMV condition. The 3-level pooled effect was g=-0.526 (95% confidence interval [CI], -0.742 to -0.310; P<.001). All 3 frequency-band estimates favored FMV, with 95% CIs <0, and no differences were detected among frequency bands (Wald; P=.948); continuous frequency was not associated with effect size (β=0.00117 per Hz; 95% CI, -0.00117 to 0.00352; P=.326). All 12 finger estimates were negative. Leave-one-out analyses retained CIs <0, and Egger regression on 10 independent report-level aggregates suggested possible small-study effects (bias coefficient=-6.10; P=.002). Certainty in the primary outcome was moderate.
CONCLUSIONS: FMV probably reduces poststroke upper limb spasticity. The antispasticity effect was observed across the 30-300 Hz range studied, with no frequency-related modification detected, and finger estimates showed the most uniform effect direction. These findings support flexible frequency selection within studied protocols. Larger trials are needed to refine amplitude, dose, and muscle targeting.
DATA SOURCES: PubMed, Excerpta Medica Database, Web of Science, Cumulative Index to Nursing and Allied Health Literature, PEDro, and Cochrane Central Register of Controlled Trials were searched from inception through March 2026.
STUDY SELECTION: Studies of adults with poststroke upper limb spasticity were eligible if they applied FMV to the upper limb and reported the Modified Ashworth or Tardieu Scale. Controlled parallel, randomized crossover, and comparative repeated-measures studies were eligible, including peer-reviewed reports and preprints with sufficient outcome data.
DATA EXTRACTION: Two reviewers independently extracted data and assessed the risk of bias. Hedges' g was calculated from pre-to-post change scores and synthesized with a 3-level random-effects model (restricted maximum likelihood). Certainty was assessed with the Grading of Recommendations Assessment, Development, and Evaluation. The review was registered in PROSPERO (CRD420251181549).
DATA SYNTHESIS: In total, 11 reports representing 11 independent participant samples contributed 32 effect estimates from 285 participants assigned to or receiving an FMV condition. The 3-level pooled effect was g=-0.526 (95% confidence interval [CI], -0.742 to -0.310; P<.001). All 3 frequency-band estimates favored FMV, with 95% CIs <0, and no differences were detected among frequency bands (Wald; P=.948); continuous frequency was not associated with effect size (β=0.00117 per Hz; 95% CI, -0.00117 to 0.00352; P=.326). All 12 finger estimates were negative. Leave-one-out analyses retained CIs <0, and Egger regression on 10 independent report-level aggregates suggested possible small-study effects (bias coefficient=-6.10; P=.002). Certainty in the primary outcome was moderate.
CONCLUSIONS: FMV probably reduces poststroke upper limb spasticity. The antispasticity effect was observed across the 30-300 Hz range studied, with no frequency-related modification detected, and finger estimates showed the most uniform effect direction. These findings support flexible frequency selection within studied protocols. Larger trials are needed to refine amplitude, dose, and muscle targeting.